38
$10M
36K$1B
8.4K$1B
201$50M$100M
123$10M
51$10M$50M
14$10M
98$10M$50M
187$10M$50M
51$10M$50MEnlaza Therapeutics uses 8 technology products and services including Google Analytics, Cloudflare, MySQL, and more. Explore Enlaza Therapeutics's tech stack below.
| Enlaza Therapeutics Email Formats | Percentage |
| FLast@enlazatx.com | 96% |
| FirLast@enlazatx.com | 1% |
| First-Last@enlazatx.com | 2% |
| FiLast@enlazatx.com | 1% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-Lock™ platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.
Company Overview
Media & News
Funding & FinancialsEnlaza Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Apr 30, 2024 in the amount of $100M.
Enlaza Therapeutics's revenue is in the range of $10M
Funding & FinancialsEnlaza Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Apr 30, 2024 in the amount of $100M.
Enlaza Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com